Sprint Bioscience — Investor Relations & Filings
Filings indexed
1
across all filing types
Latest filing
2023-06-13
Regulatory Filings
Country
SE
Sweden
Listing
ST
SPRINT
Sprint Bioscience is a pharmaceutical company specializing in the early-stage development of innovative drug candidates for oncology. The company utilizes a fragment-based drug discovery (FBDD) platform to efficiently identify and advance small-molecule therapies targeting difficult-to-treat cancers. Its business model is centered on out-licensing these drug programs to global pharmaceutical companies during the preclinical phase for further development and commercialization.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Proventus Bioscience Breaks Ground in Quebec | 2023-06-13 | English |
Browse filings by year
1 year| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2023
1 filing
| |||||
| 5274058 | Proventus Bioscience Breaks Ground in Quebec | 2023-06-13 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
ONCIMMUNE HOLDINGS PLC
Immunodiagnostics company specializing in antibody and auto…
|
ONC | GB | Professional, scientific and te… |
|
Oncocross Co.,Ltd.
An AI biotechnology firm that develops drugs by predicting …
|
382150 | KR | Professional, scientific and te… |
|
ONCODESIGN
Develops therapeutic and diagnostic solutions for resistant…
|
ALONC | FR | Professional, scientific and te… |
|
Onco-Innovations
Biotechnology firm developing next-generation cancer therap…
|
ONCO | CA | Professional, scientific and te… |
|
OncoTherapy Science, Inc.
Biopharmaceutical company researching and developing novel …
|
4564 | JP | Professional, scientific and te… |
|
Optipharm.CO.,LTD
Develops animal health solutions, biotherapeutics, and xeno…
|
153710 | KR | Professional, scientific and te… |
|
ORAGENICS INC
Biotechnology company developing intranasal therapeutics fo…
|
OGEN | US | Professional, scientific and te… |
|
ORGANOIDSCIENCES LTD.
Develops organoid-based technologies for drug development a…
|
476040 | KR | Professional, scientific and te… |
|
Orum Therapeutics, Inc.
Clinical-stage biotech developing degrader-antibody conjuga…
|
475830 | KR | Professional, scientific and te… |
|
OSR Holdings, Inc.
A healthcare holding company acquiring and developing innov…
|
OSRH | US | Professional, scientific and te… |
Sprint Bioscience via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/8269/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=8269 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=8269 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=8269 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 8269}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Sprint Bioscience (id: 8269)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.